PubRank

Andreas Perrot

Author PubWeight™ 52.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 2012 2.28
2 Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 2003 2.12
3 RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med 2012 1.97
4 Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail 2011 1.70
5 Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010 1.58
6 Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res 2006 1.58
7 Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia. Ann Neurol 2003 1.54
8 Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Rev Port Cardiol 2005 1.47
9 Calcineurin in human heart hypertrophy. Circulation 2002 1.47
10 Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One 2009 1.43
11 [Familial dilated cardiomyopathy]. Herz 2005 1.42
12 A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet 2009 1.32
13 Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A 2008 1.23
14 A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Hum Mutat 2008 1.21
15 Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 2003 1.14
16 Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur J Hum Genet 2002 1.13
17 Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum Mol Genet 2008 1.13
18 Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm 2009 1.07
19 Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy. Am J Cardiol 2002 1.05
20 Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding. Hum Mutat 2006 1.00
21 Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet 2013 1.00
22 Molecular genetics of congenital atrial septal defects. Clin Res Cardiol 2009 0.99
23 Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy. Basic Res Cardiol 2011 0.98
24 A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Mol Genet Metab 2008 0.95
25 Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells. Am J Physiol Heart Circ Physiol 2004 0.94
26 A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties. Biochem Biophys Res Commun 2011 0.94
27 Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects. PLoS One 2011 0.93
28 Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet 2010 0.91
29 Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet 2012 0.88
30 Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 2012 0.87
31 Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice. J Med Genet 2011 0.86
32 Mutations in the EGF-CFC gene cryptic are an infrequent cause of congenital heart disease. Pediatr Cardiol 2006 0.85
33 Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure. Am J Med 2004 0.85
34 Dilated cardiomyopathy: more genes means more phenotypes. Eur Heart J 2005 0.84
35 The G-231A polymorphism in the endothelin-A receptor gene is associated with lower aortic pressure in patients with dilated cardiomyopathy. Am J Hypertens 2007 0.82
36 Variations in DSG2: V56M, V158G and V920G are not pathogenic for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med 2008 0.82
37 Is there a common genetic basis for all familial cardiomyopathies? Eur J Heart Fail 2006 0.82
38 Mutational analysis of the PITX2 and NKX2-5 genes in patients with idiopathic atrial fibrillation. Int J Cardiol 2010 0.80
39 Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy. Eur J Hum Genet 2010 0.80
40 Returning hypertrophy after surgery in a patient with hypertrophic cardiomyopathy caused by a myosin-binding protein C mutation. Int J Cardiol 2005 0.79
41 Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism. J Invasive Cardiol 2007 0.78
42 Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2013 0.78
43 Deletion of Glu at codon 13 in the TCAP gene encoding the Z-disc protein titin-cap/telethonin is a rare non-synonymous polymorphism. Mol Genet Metab 2006 0.77
44 "MLP: A Stress Sensor Goes Nuclear" by Sylvia Gunkel, Jörg Heineke, Denise Hilfiker-Kleiner, Ralph Knöll, J Mol Cell Cardiol. 2009;47(4):423-5. J Mol Cell Cardiol 2009 0.77
45 Letter by Geier et al regarding article, "Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction". Circulation 2007 0.76
46 Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy. Med Sci Monit 2008 0.76
47 ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure. Circ Cardiovasc Genet 2015 0.75
48 Mitochondrial transcription factors TFA, TFB1 and TFB2: a search for DNA variants/haplotypes and the risk of cardiac hypertrophy. Dis Markers 2008 0.75
49 Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy. Mol Genet Metab 2007 0.75
50 Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients. Int J Cardiol 2009 0.75
51 [Molecular basis of heart failure and dilated cardiomyopathy]. Herz 2002 0.75